Northeastern University — 2024
University of Louisiana at Lafayette — 2014
A. Odoux, D. Jindal, T.C. Tamas, B. W.H. Lim, D. Pollard, W. Xu (2016)
"Experimental and molecular dynamics studies showed the CBP K1X mutation affects the stability of CBP:c-Myb complex"
Computational Biology and Chemistry. 62: 47–59
Healing Hope International — Nonprofit Organization  | 04/2024 – Present
Leads observational and outcomes-focused studies in traumatic brain injury, hypoxic-ischemic encephalopathy, and immune modulating therapies.
Oversees clinical trial registration, protocol development, and PRS review on ClinicalTrials.gov, ensuring compliance with international ethical frameworks.
Directs cross-border initiatives in regenerative medicine, neurorestoration, and translational biologics with a focus on real-world evidence generation.
Designs and manages study frameworks to evaluate safety, functional outcomes, and longitudinal recovery in neurologic injury populations.
KBI Biopharma  | 03/2022 – 04/2024
Manufactured cell therapy products per batch records using aseptic techniques for cell culture feeding, expansion, counting, and cryopreservation in a cleanroom environment.
Documented manufacturing procedures, line clearance, and cleaning per Good Documentation Practices. Contributed to non-conformance, deviation, and CAPA documentation.
Managed biobanking, seed material dispensation, and finished product accountability. Performed equipment maintenance per SOPs.

Pennington Biomedical Research Center — 9/2014–12/2014
Conducted pre-clinical trials on adipose tissue calculation accuracy using ultrasound, near-infrared interactance, and bioelectrical impedance. Researched lifespan impact of artificial sweeteners on C. elegans under Dr. Jolene Zheng. Received HIPAA, CITI, and Ethics certifications.
University of Louisiana at Lafayette — 8/2013–12/2014
Conducted independent projects on protein interactions via bacterial and yeast transformation. Modeled CBP:C-Myb complex bonding. Trained students on plasmid isolation, restriction digestion, DNA recombination, and spectrophotometric analysis.
University of Louisiana at Lafayette — 8/2012–6/2013
Synthesized a ruthenium-based metallopharmaceutical for anticancer research using reflux and distillation. Applied atomic absorption spectroscopy, gas chromatography, and ion-selective electrodes for chemical analysis.
University of Louisiana at Lafayette  | 8/2012 – 12/2014

Built an Access database with Visual Basic to maintain records of ~4,000 chemicals across the department.
Updated 20 years of alumni contact records and managed social media for department community relations.
Conducted fundraising, advertising, and community outreach for Science Olympiad events.
North Carolina State University — 2022
Essentials of biological systems for product development, covering biopharmaceuticals, vaccines, bioprocess engineering, quality assurance, regulatory compliance, and industry innovations.
Northeastern University — 2018
International regulatory requirements for safety, performance, and efficacy of biomedical goods, including global commercialization strategies and marketing pathways.
National Institute of Health — 2017
Covered IRBs, informed consent, confidentiality, participant safety, adverse events, QA, research protocols, documentation, research misconduct, and investigational new drugs.
From foundational laboratory science at the University of Louisiana to leading international clinical research programs, T.C. Tamas has built a career spanning bench chemistry, cGMP biomanufacturing, and translational regulatory science.
cGMP operations, aseptic processing, cryopreservation, biobanking, and cleanroom compliance at commercial scale.
Observational study frameworks, protocol development, ClinicalTrials.gov registration, and outcomes-focused research in neurologic injury.
International biopharmaceutical regulatory strategy, GCP compliance, marketing pathways, and safety/efficacy frameworks for global commercialization.
Atomic absorption spectroscopy, gas chromatography, ion-selective electrodes, protein modeling, and spectrophotometric analysis.
With a decade of experience spanning academic research, cGMP biomanufacturing, and international clinical program leadership, T.C. Tamas brings a rare combination of scientific rigor and regulatory expertise to every initiative.
Northeastern University, 2024
Computational Biology & Chemistry, 2016
Good Clinical Practice, 2017
Biopharmaceutical Regulatory Affairs | Clinical Research | Cell Therapy | Translational Science